Literature DB >> 20731614

Liquisolid technology for dissolution rate enhancement or sustained release.

Amrit B Karmarkar1, Indrajeet D Gonjari, Avinash H Hosmani.   

Abstract

IMPORTANCE OF THE FIELD: Most of the drugs that have been invented are of BCS Class II. Therefore, dissolution rate enhancement is the key aspect for absorption of these drugs. Liquisolid technology is very efficient in the dissolution rate enhancement of these drugs. Moreover, use of other polymers such as Eudragit and hydroxypropyl methylcellulose in the liquisolid approach can cause sustained release of drugs. This review focuses on the formulation approaches of liquisolid tablets or compacts along with its fundamental principles. AREAS COVERED IN THIS REVIEW: The review focuses on the developments in liquisolid technology from 1998 to 2009 with in vitro and in vivo performance of the dosage forms prepared using this technology. WHAT THE READER WILL GAIN: Benefits of this review include a concise evaluation of this technology by focusing on the scope of future developments to be done using this technique. TAKE HOME MESSAGE: Liquisolid technology, the next generation of powder solution technology, can be helpful for enhancing dissolution rates of poorly water-soluble drugs as well as effective at sustaining drug release.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20731614     DOI: 10.1517/17425247.2010.511173

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  5 in total

1.  Enhancement of the Oral Bioavailability of Fexofenadine Hydrochloride via Cremophor(®) El-Based Liquisolid Tablets.

Authors:  Soad Ali Yehia; Mohamed Shafik El-Ridi; Mina Ibrahim Tadros; Nolwa Gamal El-Sherif
Journal:  Adv Pharm Bull       Date:  2015-11-30

2.  In vitro and in vivo evaluation of ordered mesoporous silica as a novel adsorbent in liquisolid formulation.

Authors:  Bao Chen; Zhouhua Wang; Guilan Quan; Xinsheng Peng; Xin Pan; Rongchang Wang; Yuehong Xu; Ge Li; Chuanbin Wu
Journal:  Int J Nanomedicine       Date:  2012-01-06

3.  Modern evaluation of liquisolid systems with varying amounts of liquid phase prepared using two different methods.

Authors:  Barbora Vraníková; Jan Gajdziok; David Vetchý
Journal:  Biomed Res Int       Date:  2015-05-17       Impact factor: 3.411

4.  Formulation and in vitro evaluation of self-nanoemulsifying liquisolid tablets of furosemide.

Authors:  Lena Dalal; Abdul Wahab Allaf; Hind El-Zein
Journal:  Sci Rep       Date:  2021-01-14       Impact factor: 4.379

Review 5.  Pharmaceutical Dispersion Techniques for Dissolution and Bioavailability Enhancement of Poorly Water-Soluble Drugs.

Authors:  Xingwang Zhang; Huijie Xing; Yue Zhao; Zhiguo Ma
Journal:  Pharmaceutics       Date:  2018-06-23       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.